A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and the effect of food on
KQ-791. Each participant may receive up to 3 single doses of KQ-791 (at up to 3 different
dose levels) and 1 placebo dose over the course of the study. Up to 6 escalating dose levels
may be studied, in two distinct groups or cohorts.